This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Ophthalmology, Other  • Alert me on articles by topic

James D. Lindsey, PhD; Heather L. Jones, MPH; Eleanore G. Hewitt, BA; Mila Angert, MS; Robert N. Weinreb, MD

Arch Ophthalmol. 2001;119:853-860.

Objective  Topical administration of latanoprost sometimes induces gradual iris darkening. The present study was undertaken to determine if latanoprost can increase transcription of the gene for tyrosinase, an important enzyme in the biosynthesis of melanin. Results from brown, hazel, and blue irides were compared.

Methods  Iris tissue was isolated from 30 pairs of postmortem human donor eyes, and 2 iris segments from each eye were incubated in tissue culture medium supplemented with 200nM latanoprost acid or vehicle for 7 days. Tyrosinase messenger RNA (mRNA) was determined using real-time polymerase chain reaction analysis (TaqMan quantitative polymerase chain reaction). Results for tyrosinase mRNA were normalized according to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA in each sample.

Results  Tyrosinase mRNA expression was similar in blue and hazel irides, and ranged from 0.7-fold to 12.6-fold greater than GAPDH expression. In contrast, control brown iris culture tyrosinase expression ranged from 6.4-fold to 265-fold greater than GAPDH expression. Induction of tyrosinase mRNA by latanoprost was below threshold in all the blue iris cultures (n = 8 pairs), present in 1 of 9 hazel iris cultures, and present in 5 of 13 brown iris cultures. Mean induction in the responding hazel iris cultures was 1.40-fold. Mean induction among the responding brown iris cultures was 2.97-fold.

Conclusions  These observations support the view that iris darkening associated with latanoprost treatment reflects induction of tyrosinase expression. Moreover, they suggest that the probability that latanoprost will increase tyrosinase expression is directly related to the magnitude of tyrosinase expression before treatments are initiated.

Clinical Relevance  The variability of iris darkening with latanoprost may reflect natural variation in the basal transcription of tyrosinase.

From the Glaucoma Center, University of California San Diego, La Jolla, Calif. The authors have no proprietary interest in any of the materials used in this study.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Study of Histopathological Features of Latanoprost-Treated Irides With or Without Darkening Compared With Non-Latanoprost-Treated Irides
Albert et al.
Arch Ophthalmol 2008;126:626-631.
ABSTRACT | FULL TEXT  

Sigma Receptor Antagonists Inhibit Human Lens Cell Growth and Induce Pigmentation
Wang et al.
IOVS 2005;46:1403-1408.
ABSTRACT | FULL TEXT  

A Study of Iridectomy Histopathologic Features of Latanoprost- and Non-Latanoprost-Treated Patients
Albert et al.
Arch Ophthalmol 2004;122:1680-1685.
ABSTRACT | FULL TEXT  

Sequences Associated With Human Iris Pigmentation
Frudakis et al.
Genetics 2003;165:2071-2083.
ABSTRACT | FULL TEXT  

Fine Structural Evaluation of the Iris After Unilateral Treatment With Latanoprost in Patients Undergoing Bilateral Trabeculectomy (The Mainz II Study)
Pfeiffer et al.
Arch Ophthalmol 2003;121:23-31.
ABSTRACT | FULL TEXT